SOPHiA GENETICS
SOPH
34 hedge funds and large institutions have $70.4M invested in SOPHiA GENETICS in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 5 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
100% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 5
17% more funds holding
Funds holding: 29 → 34 (+5)
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
0.12% less ownership
Funds ownership: 33.89% → 33.77% (-0.12%)
58% less capital invested
Capital invested by funds: $167M → $70.4M (-$97.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AWA
Alta Wealth Advisors
Woburn,
Massachusetts
|
+$7.15M |
| 2 |
Principal Financial Group
Des Moines,
Iowa
|
+$1.06M |
| 3 |
EDRH
Edmond de Rothschild Holding
Chambesy,
Switzerland
|
+$831K |
| 4 |
Barclays
London,
United Kingdom
|
+$293K |
| 5 |
BPC
Banque Pictet & Cie
Geneva 73,
Switzerland
|
+$259K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
-$4.53M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$2.22M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1.92M |
| 4 |
RI
RTW Investments
New York
|
-$1.75M |
| 5 |
Jennison Associates
New York
|
-$1.32M |
SOPH Hedge Fund Activity: Q2 2022 in Review
34 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in SOPHiA GENETICS (SOPH) for Q2 2022, worth a combined $70.4M — down 58% from $167M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new SOPH positions and 5 closed out — a net gain of 5 holders — while 8 added to existing stakes and 8 trimmed.
The largest buyer was Alta Wealth Advisors, opening a new position worth an estimated $7.15M. The largest seller was Pictet Asset Management (Switzerland), exiting entirely with an estimated $4.53M sold.
- 34 institutional investors held SOPHiA GENETICS (SOPH) as of Q2 2022, up from 29 in Q1 2022.
- Funds reported $70.4M of SOPHiA GENETICS stock for Q2 2022, down 58% quarter-over-quarter.
- 10 funds opened new SOPHiA GENETICS positions in Q2 2022 and 5 closed out, a net change of +5 holders.
- The largest SOPHiA GENETICS buyer in Q2 2022 was Alta Wealth Advisors, an estimated $7.15M added.
- The largest SOPHiA GENETICS seller in Q2 2022 was Pictet Asset Management (Switzerland), an estimated $4.53M sold.
Based on aggregated 13F filings for Q2 2022.